Sign up to save your podcasts
Or
Share Can Cancer Ever Become a Managed Disease? − How AI-driven Cancer Research in Hungary Can Help Make It Happen
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Can Cancer Ever Become a Managed Disease? − How AI-driven Cancer Research in Hungary Can Help Make It Happen
Many people don’t know the birthplace of digital pathology is Budapest, and a thriving local ecosystem has now paved the way for a new Pathology Innovation Incubator that is meant to take AI-driven cancer diagnostics to the next level. We asked the CEOs of the two global leaders that teamed up for the effort, Mr. Steven Lynum of Epredia
and Dr. Béla Molnár of 3DHistech, to talk about the potential this endeavor holds, the role the Hungarian operation can play in the process, and most of all, whether cancer could become a chronic disease that can be managed like diabetes.
Our guests also reflected on
- the chances that waiting times in Hungary could be cut because these efforts take
place in Hungary
- what challenges scientists face when using AI to support cancer diagnostics
- staying competitive with emerging companies
- what might be possible if infinite funds were available for cancer research
Read the summary of, and find more links to, the podcast at https://hipa.hu/podcast/, and don’t forget to follow and
rate it. Any comments? Send us a message to [email protected].
Check out our brand-new editorial content, HIPA
Stories – Behind the Ribbon Cutting that showcases exciting tales of the local
investor community in the form of in-depth reports. All articles are available
at https://hipa.hu/report/.
All rights reserved ©HIPA
Nonprofit Zrt. - Hungarian
Investment Promotion Agency.
View all episodes
By Invest In Hungary by HIPAMany people don’t know the birthplace of digital pathology is Budapest, and a thriving local ecosystem has now paved the way for a new Pathology Innovation Incubator that is meant to take AI-driven cancer diagnostics to the next level. We asked the CEOs of the two global leaders that teamed up for the effort, Mr. Steven Lynum of Epredia
and Dr. Béla Molnár of 3DHistech, to talk about the potential this endeavor holds, the role the Hungarian operation can play in the process, and most of all, whether cancer could become a chronic disease that can be managed like diabetes.
Our guests also reflected on
- the chances that waiting times in Hungary could be cut because these efforts take
place in Hungary
- what challenges scientists face when using AI to support cancer diagnostics
- staying competitive with emerging companies
- what might be possible if infinite funds were available for cancer research
Read the summary of, and find more links to, the podcast at https://hipa.hu/podcast/, and don’t forget to follow and
rate it. Any comments? Send us a message to [email protected].
Check out our brand-new editorial content, HIPA
Stories – Behind the Ribbon Cutting that showcases exciting tales of the local
investor community in the form of in-depth reports. All articles are available
at https://hipa.hu/report/.
All rights reserved ©HIPA
Nonprofit Zrt. - Hungarian
Investment Promotion Agency.